Tight junction - Wikipedia, the free encyclopedia
An Overview of the Tight Junction at Zonapse.Net; Occludin in Focus at Zonapse.Net; Some good pictures of tight junctions at nastech.com; MeSH Tight+Junctions
Procter & Gamble quits deal with Nastech
Nastech Pharmaceutical Co. said Wednesday that global consumer products giant Procter & Gamble had pulled out of a collaboration with the Bothell biotech firm to develop a nasal ...
Nastech selling shares to advance efforts
Nastech Pharmaceutical said Friday it would raise almost $8 million in a stock offering -- cash the company said it would use to advance its RNA interference programs.
Nastech Pharmaceutical - Company Profile on LinkedIn
This is the limited version of the Nastech Pharmaceutical company profile: Join LinkedIn or Sign In to see more information. Nastech Pharmaceutical Company, Inc., a biopharmaceutical ...
Nastech Pharmaceutical Company Initiates Plan for Corporate ...
Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs. Company to Host Webcast and Conference ...
Nastech's results demonstrate RNAi potency for flu
Nastech Pharmaceuticals presents data demonstrating the effectiveness of its small interfering RNA (siRNA) therapeutics to target and inhibit influenza viral production, which is ...
Nastech Pharmaceutical Company Inc. Q1 2008 Earnings Call Transcript ...
Nastech Pharmaceutical Company Inc. Q1 2008 Earnings Call. May 8, 2008 4:30 pm ET. Executives. Matthew Haines - Senior Director of IR and Corporate Communications
Nastech Initiates Clinical Development Of Rapid Acting Insulin Nasal ...
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today the initiation of a Phase I pharmacokinetic study designed to evaluate the safety, bioavailability and glucose ...
